Prevention and Treatment With Hydroxychloroquine + Azithromycin of Acute Respiratory Syndrome Induced by COVID-19

NCT04954040 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

132

Enrollment

OTHER

Sponsor class

Conditions

Acute Respiratory Distress Syndrome
Covid19

Interventions

DRUG: Hydroxychloroquine Pill + Azithromycin Pill
DRUG: SOC

Sponsor

Maimónides Biomedical Research Institute of Córdoba